Collagen, Type III Proteins (COL3)

Coagulation factor II is proteolytically cleaved to form thrombin in the first step of the coagulation cascade which ultimately results in the stemming of blood loss. Additionally we are shipping Collagen, Type III Antibodies (187) and Collagen, Type III Kits (69) and many more products for this protein.

list all proteins Gene Name GeneID UniProt
COL3 2147 P00734
Mouse COL3 COL3 14061 P19221
COL3 29251  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top Collagen, Type III Proteins at

Showing 10 out of 13 products:

Catalog No. Origin Source Conjugate Images Quantity Supplier Delivery Price Details
Human Human Un-conjugated Western Blot of COLLAGEN III Lane 1: Human Collagen III Load: 100 ng per lane Primary antibody: Collagen III Antibody at 1:1000 o/n at 4°C Secondary antibody: 649 Goat anti-rabbit at 1:20,000 for 30 min at RT Block: ABIN925618 for 30 min at RT Predicted/Observed size: 138 kDa, 138 kDa 500 μg Log in to see 7 to 9 Days
Cow Cow Un-conjugated   500 μg Log in to see 7 to 9 Days
Human Human Un-conjugated Lane 1: Human Collagen III. Load: 100 ng per lane. Primary antibody: Collagen III antibody at 1:1000 ON at 4 deg C. Secondary antibody: Dylight (TM) 649 Goat anti-rabbit at 1:20, 000 for 30 min at RT. Block for 30 min at RT. 500 μg Log in to see 9 to 11 Days
Rat Rat Un-conjugated   10 mg Log in to see 6 to 8 Days
Cow Cow Un-conjugated   10 mg Log in to see 6 to 8 Days
Yeast (Pichia pastoris) Human Un-conjugated   1 mg Log in to see 2 to 3 Days
Human Human Un-conjugated   0.5 mg Log in to see 2 to 3 Days
Human Human Un-conjugated   0.5 mg Log in to see 11 to 16 Days
Yeast (Pichia pastoris) Human Un-conjugated   10 mg Log in to see 2 to 3 Days
Cow Cow Un-conjugated   0.5 mg Log in to see 3 to 4 Days

COL3 Proteins by Origin and Source

Origin Expressed in
Human ,
Rat (Rattus)

More Proteins for Collagen, Type III (COL3) Interaction Partners

Human Collagen, Type III (COL3) interaction partners

  1. Thrombin (show F2 Proteins) generation had a limited impact as biomarker of venous thromboembolism.

  2. Polymorphisms of F2, PROC, PROZ, and F13A1 Genes are Associated With Recurrent Spontaneous Abortion in Chinese Han Women.

  3. the prothrombotic activity of FII is the result of a polymorphism and of a missense mutation, whereas that of FV derives only from a polymorphism. The observation that a clotting factor (show F7 Proteins) defect may be associated with both bleeding or venous thrombosis depending on the site of the mutation has caused an extensive reevaluation of the blood clotting mechanism.

  4. Findings provide evidence for a relationship between two genes-three mutations-of the cardiovascular disease (CVD genes panel and recurrent pregnancy loss (RPL). These genotypes include the heterozygous state of the factor II G20210A mutation.

  5. digestion of thrombin (show F2 Proteins) by P. aeruginosa elastase leads to the release of the C-terminal thrombin (show F2 Proteins)-derived peptide FYT21, which inhibits pro-inflammatory responses to several pathogen-associated molecular patterns.

  6. Prothrombin (show F2 Proteins) gene mutation is rare in Budd-Chiari syndrome patients in India.

  7. In HBV-related cirrhosis, the combination of miR (show MLXIP Proteins)-122, AFP (show AFP Proteins) and PIVKA-II enables the identification of patients at higher risk of hepatocellular carcinoma development.

  8. Data, including data using network analysis, suggest that angiotensinogen (AGT (show AGT Proteins)), mitogen-activated protein kinase-14 (MAPK14 (show MAPK14 Proteins)), and prothrombin (show F2 Proteins) (F2) in placental villous tissues are core factors in early embryonic development; these studies involved proteomics and bioinformatics analysis of altered protein expression in placental villous tissue from early recurrent miscarriage patients in comparison to control tissues.

  9. Arg596Gln mutation is a risk factor for Chinese patients with venous thromboembolism due to its moderately decreased clotting activity but strong resistance to antithrombin (show SERPINC1 Proteins) inhibition.

  10. The induction of TG by BXPC3 cells was mainly driven by the TF pathway while TG generation triggered by MCF7 cells was also driven by FXII (show F12 Proteins) activation.

Mouse (Murine) Collagen, Type III (COL3) interaction partners

  1. Platelet derived microparticles formed in sepsis are a potent inducer of thrombin (show F2 Proteins) generation via phosphatidylserine exposure, and activation of both the intrinsic and extrinsic pathway of coagulation.

  2. These findings imply that a thrombin (show F2 Proteins)-pericyte interaction in the brain could be a significant mechanism responsible for blood-brain barrier dysfunction under obesity-associated diabetic conditions and thus could represent a therapeutic target for central nervous system complications of diabetes.

  3. mutations were introduced into the endogenous fII gene, resulting in expression of prothrombin (show F2 Proteins) carrying 3 amino acid substitutions (R157A, R268A, and K281A) to limit activation events to yield only fIIa(Meizothrombin) Homozygous fII(MZ) mice are viable, express fII levels comparable with fII(Wild type) mice, and have reproductive success.

  4. Biglycan (show BGN Proteins) plays a protective role during the progression of atherosclerosis in ApoE (show APOE Proteins)-deficient mice by inhibiting thrombin (show F2 Proteins) generation.

  5. allosteric inhibitor SbO4L targets the glycoprotein Ibalpha (show GP1BA Proteins)-binding and heparin-binding site of thrombin (show F2 Proteins)

  6. thrombin (show F2 Proteins)/PAR-1 (show MARK2 Proteins) interaction regulated MCP-1 (show CPT1B Proteins), TF, MCSF (show CSF1 Proteins) and IL-6 (show IL6 Proteins) production.

  7. Observations illustrate the role of thrombin (show F2 Proteins) as a pleiotropic atherogenic molecule under conditions of hypercholesterolemia and suggest the utility of its inhibition with locally acting antithrombin (show SERPINC1 Proteins) nanoparticle therapeutics.

  8. Thrombin (show F2 Proteins)-PAR1 (show F2R Proteins) signaling, via nitric oxide and EPCR (show PROCR Proteins), promotes hematopoietic stem cell (HSC (show FUT1 Proteins)) mobilization.

  9. Primary tumor growth by colon cancer cells was reduced by reduction of circulating prothrombin. There were lower mitotic indices and invasiveness. This growth relied upon 2 targets of thrombin-mediated proteolysis, protease: PAR-1 and fibrinogen.

  10. Thrombin (show F2 Proteins) promotes sustained signaling and inflammatory gene expression through the CDC25 (show CDC25C Proteins) and Ras-associating domains of phospholipase C epsilon (show PLCE1 Proteins).

Collagen, Type III (COL3) Protein Profile

Protein Summary

Coagulation factor II is proteolytically cleaved to form thrombin in the first step of the coagulation cascade which ultimately results in the stemming of blood loss. F2 also plays a role in maintaining vascular integrity during development and postnatal life. Mutations in F2 leads to various forms of thrombosis and dysprothrombinemia.

Gene names and symbols associated with Collagen, Type III Proteins (COL3)

  • coagulation factor II, thrombin (F2)
  • coagulation factor II (F2)
  • Cf-2 protein
  • Cf2 protein
  • FII protein
  • prothrombin protein
  • PT protein
  • RPRGL2 protein
  • THPH1 protein
  • thrombin protein

Protein level used designations for Collagen, Type III Proteins (COL3)

prepro-coagulation factor II , prothrombin , prothrombin B-chain , serine protease , coagulation factor 2 , thrombin

2147 Homo sapiens
14061 Mus musculus
29251 Rattus norvegicus
395306 Gallus gallus
Selected quality suppliers for Collagen, Type III Proteins (COL3)
Did you look for something else?